Featured Editorial

1. Biomaterials In Ophthalmology Are Reshaping Ocular Drug Delivery 6/15/2026

   Biomaterial-based ocular drug delivery systems are transforming eye care by improving efficacy, reducing treatment burden, and enabling regenerative therapies.

2. Why Improving Drug Delivery Remains A Major Opportunity In Oncology 6/12/2026

   Engineered oncolytic viruses are emerging as a promising way to target tumors, deliver immune-stimulating payloads, and improve treatment of metastatic cancer.

3. Crossing The Brain's Barrier: Recent Advances And What Lies Ahead 6/11/2026

   Recent FDA approvals mark a breakthrough in blood-brain barrier drug delivery, validating brain-shuttle technologies and accelerating new CNS therapies.

4. Navigating Combination Products: Device Complexity And Software Integration 6/4/2026

   Software-enabled combination products demand early cross-functional alignment, regulatory foresight, and collaboration to avoid delays and accelerate patient access.

5. Improving Execution Of Biological Evaluation Of Drug Delivery Devices 6/3/2026

   This article provides a framework to streamline the biological safety assessment process, reduce testing burdens, and improve patient safety for combination products.

6. DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD 6/2/2026

   At the DDW 2026 meeting, the IBD landscape was portrayed as increasingly competitive and diversified, with emerging players and novel mechanisms challenging established standards of care.

7. From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair 6/1/2026

   Exosomes are biological vesicles used for cellular communication that can overcome CNS barriers, delivering therapeutic cargo for CNS and optic nerve injuries.

8. Risk Is the Spine: What The First 100 QMSR Inspections Reveal 5/29/2026

   The FDA has now completed just over 100 inspections under its new Quality Management System Regulation, and the agency has begun sharing preliminary observations from those inspections.

9. Advancing Autologous Stem Cell Engineering For Diabetes And Vision Loss 5/28/2026

   Advances in autologous stem cell and biomaterial engineering are transforming the future of regenerative medicine by enabling scalable, patient-derived therapies.

10. The Hidden Operational Complexities Of Home Infusion 5/20/2026

    Home infusion can lower costs and improve access, but requires complex coordination, patient readiness, logistics, and monitoring to ensure safe and effective care.